Wednesday, May 22, 2013
Epizyme Inc., of Cambridge, Mass., set terms for its proposed initial public offering (IPO), aiming to sell 4.3 million shares at a price range of $13 to $15.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.